A second site Kras(G12D) mutation that impairs PI3K binding rescues embryonic lethality, abrogates myeloproliferative disease, and delays lung tumorigenesis.

Wong, J. C., Perez-Mancera, P. A., Kim, J., Jen, K. Y., Kogan, S. C., Firestone, A. J., Collisson, Eric A, Tuveson, D. A., Shannon, K. (May 2020) A second site Kras(G12D) mutation that impairs PI3K binding rescues embryonic lethality, abrogates myeloproliferative disease, and delays lung tumorigenesis. Molecular Cancer Research, 18 (5). p. 43. ISSN 1541-7786

Item Type: Paper
CSHL Authors:
Communities: CSHL labs > Tuveson lab
Depositing User: Matthew Dunn
Date: May 2020
Date Deposited: 06 Jul 2020 18:36
Last Modified: 06 Jul 2020 18:36
URI: https://repository.cshl.edu/id/eprint/39507

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving